Alpha Cognition Inc. (ACOG) vs Compugen Ltd. (CGEN)

Alpha Cognition Inc. and Compugen Ltd. are both Biotechnology companies. Alpha Cognition Inc. and Compugen Ltd. are of similar size ($191.7M and $187.6M). Alpha Cognition Inc. has negative trailing earnings, so its P/E is not meaningful; Compugen Ltd. trades at 5.5×. Compugen Ltd. has the higher net margin (47.6% vs −137.7%) and the higher return on invested capital (0.00% vs −144.7%). Across the 15 metrics below, Compugen Ltd. leads on 13 and Alpha Cognition Inc. on 2.

Valuation

Metric ACOG CGEN Biotechnology median
P/E n/m 5.47 8.42
P/S 12.06 2.66 10.01
P/B 3.47 2.22 2.21
Price to free cash flow n/m 4.92 21.01
EV/EBITDA n/m 2.36 0.61
EV/Sales 9.41 0.97 9.41
Earnings yield (12.78%) 18.27% (31.85%)
Free cash flow yield (20.15%) 20.34% (24.58%)

Profitability

Metric ACOG CGEN Biotechnology median
Gross margin 90.37% 86.89% 65.16%
Operating margin (174.70%) 40.94% 0.00%
Net margin (137.69%) 47.55% 0.00%
Free cash flow margin (242.99%) 54.10% 0.00%
Return on equity (49.53%) 47.85% (56.36%)
Return on assets (38.33%) 23.86% (48.04%)
Return on invested capital (144.65%) 0.00% 0.00%

Growth

Metric ACOG CGEN Biotechnology median
Revenue growth (TTM) — 234.18% 6.02%
EPS growth (last fiscal year) 42.08% 337.50% 30.26%
Revenue growth, 5-year CAGR — 105.20% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG CGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 5.72 4.72
Net debt to EBITDA 2.92 (4.65) 0.96

Dividend

Metric ACOG CGEN Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ACOG CGEN Biotechnology median
Market cap 191.65m 187.56m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack